#$%^&*AU2018206685A120180802.pdf#####Abstract Pharmaceutical Compositions Comprising 15-OHEPA and Methods of Using the Same The present invention relates to the compositions, formulations and methods of treating fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and their sequelae by administration of 15-OHEPA. 1 LEGAL121360278.1 (20842038 1):CLVRH